Filing Details
- Accession Number:
- 0001209191-23-009232
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-14 17:08:54
- Reporting Period:
- 2023-02-10
- Accepted Time:
- 2023-02-14 17:08:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829069 | Bastiano Sanna | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cell & Genetic Therapies | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-10 | 902 | $294.33 | 66,368 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-02-13 | 4,340 | $298.26 | 62,028 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-02-13 | 113 | $300.39 | 61,915 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1.
- Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $300.39 (range $300.00 to $300.79).
Billionaire Hedge Funds
